Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001706106 | SCV000223429 | benign | not provided | 2019-11-14 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28469501, 28614222) |
Ambry Genetics | RCV000245105 | SCV000320295 | benign | Cardiovascular phenotype | 2016-08-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000458519 | SCV000562848 | benign | Brugada syndrome 4 | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000458519 | SCV000743845 | benign | Brugada syndrome 4 | 2017-10-13 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852602 | SCV000995305 | likely benign | Cardiomyopathy | 2018-02-11 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000458519 | SCV001159102 | likely benign | Brugada syndrome 4 | 2018-07-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000458519 | SCV002796724 | likely benign | Brugada syndrome 4 | 2021-09-30 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001706106 | SCV001923633 | likely benign | not provided | no assertion criteria provided | clinical testing |